The Singapore Agency for Science and Technology Research has launched a new Diagnostics Development Hub to help develop and commercialize diagnostic tests.
Former Introgen Therapeutics CEO David Nance founded the non-profit to promote tech commercialization and economic development by linking in-state academic researchers, angel and VC investors, entrepreneurs, and incubators.
William Luster, Charles Hamner, Tamika Stubbs, Pinku Mukherjee, Leanna Read, Lusia Guthrie
Battelle Ventures, MIT, Hepragen, Wayne State University, Defyrus, UK Ministry of Defence, Columbia U, Intelligent Bio-Systems, Kauffman Foundation
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.